Tersigni v. Wyeth

STAHL, Circuit Judge.

For a period of time in 1997, the appellant, Michael Tersigni, was prescribed Pondimin, a weight loss drug developed and sold by the appellee, Wyeth. 1 Tersig-ni later sued Wyeth, alleging that Pondi-min caused him to develop a dangerous condition known as primary pulmonary hypertension (“PPH”). The district court entered summary judgment for Wyeth on most of Tersigni’s claims, including his claim for negligent design, and allowed only a single claim for negligent failure to warn to go to trial. In separate rulings, the district court denied a pair of motions in limine in…